BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 17, 2017 4:56 PM UTC

Cell culture studies suggest inhibiting the polyadenylation factor CPSF1 or an alternative polyadenylation site on androgen receptor mRNA could help treat prostate cancer. In tissue samples from patie...